Cargando…

Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages

We investigated the intracellular survival of multidrug-resistant Acinetobacter baumannii (MDRAB) clinical isolates in macrophages, after phagocytosis, to determine their virulence characteristics. After ATCC 19606 and 5 clinical isolates of MDRAB were phagocytosed by mouse and human macrophages, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yoshinori, Unno, Yuka, Miyazaki, Chizuru, Ubagai, Tsuneyuki, Ono, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877552/
https://www.ncbi.nlm.nih.gov/pubmed/31767923
http://dx.doi.org/10.1038/s41598-019-53846-3
_version_ 1783473355077189632
author Sato, Yoshinori
Unno, Yuka
Miyazaki, Chizuru
Ubagai, Tsuneyuki
Ono, Yasuo
author_facet Sato, Yoshinori
Unno, Yuka
Miyazaki, Chizuru
Ubagai, Tsuneyuki
Ono, Yasuo
author_sort Sato, Yoshinori
collection PubMed
description We investigated the intracellular survival of multidrug-resistant Acinetobacter baumannii (MDRAB) clinical isolates in macrophages, after phagocytosis, to determine their virulence characteristics. After ATCC 19606 and 5 clinical isolates of MDRAB were phagocytosed by mouse and human macrophages, the bacterial count of MDRAB strains, R4 and R5, increased in the mouse macrophages, 24 hours after phagocytosis. Bacterial count of the strains, R1 and R2, was almost equal 4 and 24 hours after phagocytosis. Intracellular reactive oxygen species was detected in the macrophages after phagocytosis of these bacteria. Further, the strains R1, R2, R4, and R5 showed higher catalase activity than ATCC 19606. Additionally, strains R1, R4, and R5 grew more efficiently than ATCC 19606 in the presence of H(2)O(2), whereas growth of strains R2 and R3 was marginally more than that of ATCC 19606 in the presence of H(2)O(2). The MDRAB clinical isolates altered the expression of TNF-α, IL-1β, IL-6, and MIP-2 mRNA induced in J774A.1 cells, 24 hours after phagocytosis. These results provide insights into the renewed virulence characteristics of MDRAB clinical isolates. Finally, tigecycline killed MDRAB phagocytosed by the macrophages more effectively than colistin, although colistin and tigecycline are both considered effective antibiotics for the treatment of MDRAB.
format Online
Article
Text
id pubmed-6877552
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68775522019-12-05 Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages Sato, Yoshinori Unno, Yuka Miyazaki, Chizuru Ubagai, Tsuneyuki Ono, Yasuo Sci Rep Article We investigated the intracellular survival of multidrug-resistant Acinetobacter baumannii (MDRAB) clinical isolates in macrophages, after phagocytosis, to determine their virulence characteristics. After ATCC 19606 and 5 clinical isolates of MDRAB were phagocytosed by mouse and human macrophages, the bacterial count of MDRAB strains, R4 and R5, increased in the mouse macrophages, 24 hours after phagocytosis. Bacterial count of the strains, R1 and R2, was almost equal 4 and 24 hours after phagocytosis. Intracellular reactive oxygen species was detected in the macrophages after phagocytosis of these bacteria. Further, the strains R1, R2, R4, and R5 showed higher catalase activity than ATCC 19606. Additionally, strains R1, R4, and R5 grew more efficiently than ATCC 19606 in the presence of H(2)O(2), whereas growth of strains R2 and R3 was marginally more than that of ATCC 19606 in the presence of H(2)O(2). The MDRAB clinical isolates altered the expression of TNF-α, IL-1β, IL-6, and MIP-2 mRNA induced in J774A.1 cells, 24 hours after phagocytosis. These results provide insights into the renewed virulence characteristics of MDRAB clinical isolates. Finally, tigecycline killed MDRAB phagocytosed by the macrophages more effectively than colistin, although colistin and tigecycline are both considered effective antibiotics for the treatment of MDRAB. Nature Publishing Group UK 2019-11-25 /pmc/articles/PMC6877552/ /pubmed/31767923 http://dx.doi.org/10.1038/s41598-019-53846-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sato, Yoshinori
Unno, Yuka
Miyazaki, Chizuru
Ubagai, Tsuneyuki
Ono, Yasuo
Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages
title Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages
title_full Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages
title_fullStr Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages
title_full_unstemmed Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages
title_short Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages
title_sort multidrug-resistant acinetobacter baumannii resists reactive oxygen species and survives in macrophages
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877552/
https://www.ncbi.nlm.nih.gov/pubmed/31767923
http://dx.doi.org/10.1038/s41598-019-53846-3
work_keys_str_mv AT satoyoshinori multidrugresistantacinetobacterbaumanniiresistsreactiveoxygenspeciesandsurvivesinmacrophages
AT unnoyuka multidrugresistantacinetobacterbaumanniiresistsreactiveoxygenspeciesandsurvivesinmacrophages
AT miyazakichizuru multidrugresistantacinetobacterbaumanniiresistsreactiveoxygenspeciesandsurvivesinmacrophages
AT ubagaitsuneyuki multidrugresistantacinetobacterbaumanniiresistsreactiveoxygenspeciesandsurvivesinmacrophages
AT onoyasuo multidrugresistantacinetobacterbaumanniiresistsreactiveoxygenspeciesandsurvivesinmacrophages